TRPA1 promotes cisplatin-induced acute kidney injury via regulating the endoplasmic reticulum stress-mitochondrial damage
Patients should consider eating smaller, more frequent meals rather than large portions, as this approach accommodates the medication's effect on gastric emptying
42,43 Several GLP-1R agonists, including exenatide, liraglutide, and semaglutide, have been used in NASH clinical research
The practical questions are: how many people say theyre using GLP-1s today, whos interested next, and what changes do users report in everyday habits and spending
At Swiss Medica, doctors evaluate each patient individually, ensuring that the choice between stem cells, exosomes, and peptidesor their combinationis based on medical evidence and safety considerations
Perhaps NAD boosters could help with this side effect, especially given there is evidence from a small study @BrighamWomens that people have more leg endurance after 4 weeks on NMNHere's more on that study: nad.com/news/harvard-s I wouldn't go near a GLP-1 receptor if you paid me
